| [1] |
Stasi R，Newland AC.ITP：a historical perspective[J]．Br J Hematol, 2011, 153(4): 437-450.
|
| [2] |
Lee JY, Lee JH, Lee H, et al. Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea [J]. Thromb Res, 2017, 155: 86-91.
|
| [3] |
Nazarpour S, Ramezani TF, Simbar M, et al. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease[J]. Eur J Endocrinol, 2017, 176(2): 253-265.
|
| [4] |
Calderwood CJ, Greer IA. The role of factor V Leiden in maternal health and the outcome of pregnancy [J]. Current drug targets, 2005, 6(5): 567-576.
|
| [5] |
Frederiksen H，Schmidt K．The incidence of idiopathic thrombocytopenicpurpura in adults increases with age [J]. Blood, 1999, 94(3): 909-913.
|
| [6] |
Rossio R, Lotta LA, Pontiggia S, et al.A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity [J]. Haematologica, 2015, 100(3): e87-e89.
|
| [7] |
Ramakrishna R, Rehman A, Ramakrishna S, et al. Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period [J]. Intern Med J, 2015, 45(7): 718-724.
|
| [8] |
Karakurt N, Uslu I, Albayrak C, et al. Neonates born to mothers with immune thrombocytopenia: 11 years experience of a single academic center [J]. Blood Coagul Fibrinolysis, 2018, 29(6): 546-550.
|
| [9] |
Zdravic D, Yougbare I, Vadasz B, et al. Fetal and neonatal alloimmunethrombocytopenia [J]. Semin Fetal Neonatal Med, 2016, 21(1): 19-27.
|
| [10] |
Loustau V, Pourrat O, Mandelbrot L, et al. Immune thrombocytopenia and pregnancy: State of knowledge and unanswered questions[J]. Rev Med Interne, 2015, 36(3): 167-172.
|
| [11] |
Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood, 2011, 117(16): 4190-4207.
|
| [12] |
McCrae KR.Thrombocytopenia in pregnancy：differential diagnosis, pathogenesis, and management [J]. Blood Rev, 2003, 17(1): 7-14.
|
| [13] |
vanVeen JJ, Nokes TJ, Makris M. The risk of spinal haematomafollowingneuraxialanaesthesiaor lumbar puncture in thrombocytopenic individuals [J]. Br J Haematol, 2010, 148(1): 15-25.
|
| [14] |
Tanaka H, Tenkumo C, Mori N, et al. Case of maternal and fetal deaths due to severe congenital thrombotic thrombocytopenic purpura(Upshaw-Schulman syndrome) during pregnancy [J]. J Obstet Gynaecol Res, 2014, 40(1): 247-249.
|
| [15] |
Rasmus KT, Rottman RL, Kotelko DM, et al. Unrecognized thrombocytopenia and regional anesthesia in parturients: are trospective review [J]. Obstet Gynecol, 1989, 73(6): 943-946.
|
| [16] |
Liu Y, Wang R, Han P, et al. Effect of recombinant human thrombopoietin on immune thrombocytopenia inpregnancy in a murine model [J]. Int Immunopharmacol, 2018, 17(67): 287-293.
|
| [17] |
Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies [J]. Teratology, 2000, 62(6): 385-392.
|
| [18] |
Nicolescu A, Vladareanu AM, Voican I, et al. Therapeutic Options for Immune Thrombocytopenia(ITP)During Pregnancy [J]. Maedica, 2013, 8(2): 182-188.
|
| [19] |
Hisano M, Tsukada N, Sago H, et al. Successful prevention of exacerbation of thrombocytopenia in a pregnant patient with idiopathic thrombocytopenic purpura by anticoagulation treatment [J]. BMC Pregnancy Childbirth, 2015, (15): 48-52.
|
| [20] |
Hachisuga K, Hidaka N, Fujita Y, et al. Can we predict neonatal thrombocytopenia in offspring of women with idiopathic thrombocytopenic purpura？[J]. Blood Research, 2014, 49(4): 259-264.
|
| [21] |
Subbaiah M, Kumar S, Roy KK, et al. Pregnancy outcome in patients with idiopathic thrombocytopenic purpura [J]. Archives of Gynecology andObstetrics, 2014, 289(2): 269-273.
|
| [22] |
Kong Z, Qin P，Xiao S, et al. A novel recombinant human thrombopoietin therapy for the management of immune thrombooytopenia in pregnancy [J]. Blood, 2017, 130(9): 1097-1103.
|
| [23] |
Wang S, Yang R, Zou P, et al. A muhicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia [J]. Int J Hematol, 2012, 96(2): 222-228.
|